Metraipolis › archive › dc_ea56765e7340

A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2 — Europe PMC PMID:40903574

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40903574
DOI
10.1038/s41586-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-10T03:46:45.016Z
SHA-256 of the archived text
8a81dc95a13503b7dfe3d758620b5a59f93eb87ce56059b7645ab97904882b7a
Stable URL of this page
https://metraipolis.com/documento/dc_ea56765e7340

How to cite

A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2 — Europe PMC PMID:40903574 — Europe PMC (en), https://europepmc.org/article/MED/40903574 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea56765e7340 (Metraipolis archive dc_ea56765e7340, sha256 8a81dc95a13503b7dfe3d758620b5a59f93eb87ce56059b7645ab97904882b7a)
BibTeX
@misc{dcea56765e7340,
  title = {A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2 — Europe PMC PMID:40903574},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40903574},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea56765e7340; sha256 8a81dc95a13503b7dfe3d758620b5a59f93eb87ce56059b7645ab97904882b7a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40903574. Agents can read the archived copy with the MCP tool read_document.